Molecular profile
- Sequence
- Ac-TPRKEPV-NH2
- Molecular Formula
- C 33 H 57 N 11 O 9
- Molecular Weight
- 751.9 g/mol
- PubChem CID
- 11765600
- CAS Number
- 129954-34-3
- Synonyms
- Selanc, TP-7, UNII – TS9JR8EP1G
Peptide research profile
N-Acetyl Selank Amidate
N-Acetyl Selank Amidate can be viewed as an improved version of Selank, exhibiting enhancements across various aspects. Research indicates that it elevates Selank's effectiveness by increasing its potency, extending its half-life, improving absorbability, and enhancing its ability to traverse the blood-brain barrier. These attributes contribute to the augmentation of Selank's effects.…
Dosing literacy
Dosing & scaling, explained
No mass-based amount example with adequate calculation context is available for this compound. This is educational source context—not a protocol or recommendation.
Calculation context
No source-supported amount ladder is shown
Enter a target amount only from your own reviewed source. The calculator can convert it into concentration, volume and device markings, but it will not infer an amount from product availability or another compound.
Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.
Schedule literacy
No independently verified schedule
Evidence context
No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.
Research best practices
Storage, handling and interpretation
Product identity
Verify the exact compound, formulation and amount against the product label or certificate before calculation.
Storage & handling
Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.
Prepared solutions
Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.
Mechanism map
How N-Acetyl Selank Amidate is being studied to work
This process map organizes available educational context. Individual claims remain subject to source-level verification.
- 01
Process stage
N-Acetyl Selank Amidate Mechanism & DNA
Gene expression and anxiety modulation
- 02
Process stage
Advanced Mechanisms and Applications
Blood-brain barrier penetration and therapeutic potential
Research orientation
What researchers are exploring
These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.
- 01
N-Acetyl Selank Amidate Mechanism & DNA
Gene expression and anxiety modulation
- 02
Advanced Mechanisms and Applications
Blood-brain barrier penetration and therapeutic potential
Evidence map
What is known—and what still needs verification
Available context is organized without assigning unsupported study models or evidence grades.
- Source review pending
N-Acetyl Selank Amidate Mechanism & DNA
Gene expression and anxiety modulation
- Source review pending
Advanced Mechanisms and Applications
Blood-brain barrier penetration and therapeutic potential
Technical reference
Identity, limitations and unknowns
Important limitations
- Individual claims and source links have not yet completed editorial verification.
- Evidence level, applicable study model, formulation, route and population remain unassigned.
Source review
1 links awaiting verification
- Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending